Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Autophagy Inducing Compound and the Uses thereof


Summary

This relates to a composition including an autophagy inducing compound used to degrade abnormal protein deposit in the nervous system by inducing autophagy and related methods of treatment, such as treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease associated with abnormal protein aggregation and/or deposition and cancer.


Technology Benefits

non-toxicity, effective


Technology Application

Treat Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, spinocerebellar ataxia, oculopharyngeal muscular dystrophy, prion diseases, fatal familial insomnia, alpha-1 antitrypsin deficiency, dentatorubral pallidoluysian atrophy, frontal temporal dementia, progressive supranuclear palsy, x-linked spinobulbar muscular atrophy, and neuronal intranuclear hyaline inclusion disease and cancer.


Detailed Technology Description

The present invention discloses novel compositions including IsoRhy and tetracyclic oxindole alkaloids that induce autophagy in neurons to degrade protein aggregates independent of mTOR both in vivo and in vitro and the application thereof in treating diseases that can benefit from autophagy inducement and free from mTOR associated complications.


Industry

Disease Diagnostic/Treatment


Sub Group

Cancer/Tumor


Application Date

2012.03.15


Application No.

US 13/420,628


Others

Published


ID No.

A61/LM/Auto/US01


Country/Region

Hong Kong

For more information, please click Here
Business of IP Asia Forum
Desktop View